Literature DB >> 25587908

Multivariate normative comparison, a novel method for more reliably detecting cognitive impairment in HIV infection.

Tanja Su1, Judith Schouten, Gert J Geurtsen, Ferdinand W Wit, Ineke G Stolte, Maria Prins, Peter Portegies, Matthan W A Caan, Peter Reiss, Charles B Majoie, Ben A Schmand.   

Abstract

OBJECTIVE: The objective of this study is to assess whether multivariate normative comparison (MNC) improves detection of HIV-1-associated neurocognitive disorder (HAND) as compared with Frascati and Gisslén criteria.
METHODS: One-hundred and three HIV-1-infected men with suppressed viremia on combination antiretroviral therapy (cART) for at least 12 months and 74 HIV-uninfected male controls (comparable regarding age, ethnicity, sexual orientation, premorbid intelligence and educational level), aged at least 45 years, underwent neuropsychological assessment covering six cognitive domains (fluency, attention, information processing speed, executive function, memory, and motor function). Frascati and Gisslén criteria were applied to detect HAND. Next, MNC was performed to compare the cognitive scores of each HIV-positive individual against the cognitive scores of the control group.
RESULTS: HIV-infected men showed significantly worse performance on the cognitive domains of attention, information processing speed and executive function compared with HIV-uninfected controls. HAND by Frascati criteria was highly prevalent in HIV-infected [48%; 95% confidence interval (95% CI) 38-58] but nearly equally so in HIV-uninfected men (36%; 95% CI 26-48), confirming the low specificity of this method. Applying Gisslén criteria, HAND-prevalence was reduced to 5% (95% CI 1-9) in HIV-infected men and to 1% (95% CI 1-3) among HIV-uninfected controls, indicating better specificity but reduced sensitivity. MNC identified cognitive impairment in 17% (95% CI 10-24) of HIV-infected men and in 5% (95% CI 0-10) of the control group (P = 0.02, one-tailed), showing an optimal balance between sensitivity and specificity.
CONCLUSION: Prevalence of cognitive impairment in HIV-1-infected men with suppressed viremia on cART estimated by MNC was much higher than that estimated by Gisslén criteria, while the false positive rate was greatly reduced compared with the Frascati criteria. VIDEO ABSTRACT: :

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25587908     DOI: 10.1097/QAD.0000000000000573

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  33 in total

1.  Insights into end-organ injury in HIV infection: dynamics of monocyte trafficking to the brain in SIV encephalitis.

Authors:  Yuri Persidsky
Journal:  Am J Pathol       Date:  2015-05-08       Impact factor: 4.307

Review 2.  HIV-associated neurocognitive disorder.

Authors:  David B Clifford
Journal:  Curr Opin Infect Dis       Date:  2017-02       Impact factor: 4.915

3.  A comparison of the sensitivity, stability, and reliability of three diagnostic schemes for HIV-associated neurocognitive disorders.

Authors:  Savanna M Tierney; David P Sheppard; Victoria M Kordovski; Marika P Faytell; Gunes Avci; Steven Paul Woods
Journal:  J Neurovirol       Date:  2017-01-20       Impact factor: 2.643

4.  Elevated rates of mild cognitive impairment in HIV disease.

Authors:  David P Sheppard; Jennifer E Iudicello; Mark W Bondi; Katie L Doyle; Erin E Morgan; Paul J Massman; Paul E Gilbert; Steven Paul Woods
Journal:  J Neurovirol       Date:  2015-07-03       Impact factor: 2.643

5.  Predictors and Impact of Self-Reported Suboptimal Effort on Estimates of Prevalence of HIV-Associated Neurocognitive Disorders.

Authors:  Andrew J Levine; Eileen Martin; Ned Sacktor; Cynthia Munro; James Becker
Journal:  J Acquir Immune Defic Syndr       Date:  2017-06-01       Impact factor: 3.731

6.  Cross-sectional analysis of cognitive function using multivariate normative comparisons in men with HIV disease.

Authors:  Zheng Wang; Samantha A Molsberry; Yu Cheng; Lawrence Kingsley; Andrew J Levine; Eileen Martin; Cynthia A Munro; Ann Ragin; Leah H Rubin; Ned Sacktor; Eric C Seaberg; James T Becker
Journal:  AIDS       Date:  2019-11-15       Impact factor: 4.177

7.  Altered neuropsychological performance and reduced brain volumetrics in people living with HIV on integrase strand transfer inhibitors.

Authors:  Jane A O'Halloran; Sarah A Cooley; Jeremy F Strain; Anna Boerwinkle; Robert Paul; Rachel M Presti; Beau M Ances
Journal:  AIDS       Date:  2019-07-15       Impact factor: 4.177

Review 8.  Cortical consequences of HIV-1 Tat exposure in rats are enhanced by chronic cocaine.

Authors:  Wesley N Wayman; Lihua Chen; Amanda L Persons; T Celeste Napier
Journal:  Curr HIV Res       Date:  2015       Impact factor: 1.581

9.  Machine learning models reveal neurocognitive impairment type and prevalence are associated with distinct variables in HIV/AIDS.

Authors:  Wei Tu; Patricia A Chen; Noshin Koenig; Daniela Gomez; Esther Fujiwara; M John Gill; Linglong Kong; Christopher Power
Journal:  J Neurovirol       Date:  2019-09-13       Impact factor: 2.643

10.  Multivariate Pattern Analysis of Volumetric Neuroimaging Data and Its Relationship With Cognitive Function in Treated HIV Disease.

Authors:  Jonathan Underwood; James H Cole; Robert Leech; David J Sharp; Alan Winston
Journal:  J Acquir Immune Defic Syndr       Date:  2018-08-01       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.